Clearance Summary
MODIFICATION TO: NUCAMMA RX received FDA 510(k) clearance under submission number K032779, sponsored by Is2 Research, Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Radiology review panel. The statutory decision date of record is 2003-12-17.
- Submission: K032779
- Applicant / Sponsor: Is2 Research, Inc.
- Clearance pathway: Traditional
- Review panel: Radiology
- Device class: Class II
- Regulation citation: 21 CFR 892.1200
- Decision date: 2003-12-17
Classification & Regulation
This clearance is catalogued under FDA product code KPS and 21 CFR 892.1200, within the Radiology review panel as a Class II device.